Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple Dose Safety, Pharmacokinetic-261975035
University of Kansas
Search grants from University of Kansas
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Genomic analysis of histone replacement dynamics in yeast
Washington County Chemical Health Action Collaborative Enhancement Project
Genetic Structure Of Murine Retroviruses
Neural Correlate of Pitch in Auditory Cortex
LTD and depotentiation in the hippocampus
Recently added grants:
VITAL Start (Video-intervention to Inspire Treatment Adherence for Life): Brief facility based video intervention to improve retention and adherence to ART among pregnant and breastfeeding women
Dose Determination Trial for Implementing Evidence-Basedbehavioral Interventions
Sex Differences in Major Depression: Impact of Prenatal Stress-Immune and Autonomic Dysregulation
Genetic targeting of hippocampal CA2 pyramidal neurons
Exploring Antisense Oligonucleotides as a potential therapy for Autosomal Dominant Leukodystrophy
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA075035-003
Application #
6688591
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University of Kansas
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I Single and Multiple Dose Safety, Pharmacokinetic-261975035
/ University of Kansas
NIH 2002
N01 CA
Phase I Single and Multiple Dose Safety, Pharmacokinetic-261975035
/ University of Kansas
Comments
Be the first to comment on this grant